Hearing on: Pay to Delay: Are Patent Settlements That Delay Generic Drug Market Entry Anticompetitive?
Wednesday 06/03/2009 - 9:30 A.M. 10:00 A.M.
2141 2237 Rayburn House Office Building
Subcommittee on Courts and Competition Policy
By Direction of the Chairman
Hearing Documentation
Hearing PDF (Serial No. 111-105)
Related News
No related news available
|
|
|
Witness List
Richard Feinstein
Director of the Bureau of Competition
Federal Trade Commission
Washington, DC
| |
Heather Bresch
Executive Vice President, Chief Operating Officer
Mylan Incorporated
Canonsburg, PA
|
William P. Kennedy
Chief Executive Officer
Nephron Pharmaceuticals Corporation
Orlando, FL
|
Guy Donatiello
Vice President, Intellectual Property
Endo Pharmaceuticals
Chadds Ford, PA
| |
William Vaughan
Senior Health Policy Analyst
Consumer Union
Washington, DC
|
Bret M. Dickey
Senior Vice President
Compass Lexecon
Oakland, CA
|
|